红海海绵 Callyspongia siphonella 提取物在二维和三维细胞培养中诱导乳腺癌 MCF-7 和肝癌 HepG-2 细胞株抑制生长和凋亡。

IF 2.7 4区 医学 Q3 BIOTECHNOLOGY & APPLIED MICROBIOLOGY OncoTargets and therapy Pub Date : 2024-06-25 eCollection Date: 2024-01-01 DOI:10.2147/OTT.S467083
Sana A Fadil, Fadwa A Aljoud, Ahmed R Yonbawi, Ahmad J Almalki, Rawan H Hareeri, Abrar Ashi, Mehal Atallah AlQriqri, Nada S Bawazir, Hadeel H Alshangiti, Lamiaa A Shaala, Diaa T A Youssef, Faris A Alkhilaiwi
{"title":"红海海绵 Callyspongia siphonella 提取物在二维和三维细胞培养中诱导乳腺癌 MCF-7 和肝癌 HepG-2 细胞株抑制生长和凋亡。","authors":"Sana A Fadil, Fadwa A Aljoud, Ahmed R Yonbawi, Ahmad J Almalki, Rawan H Hareeri, Abrar Ashi, Mehal Atallah AlQriqri, Nada S Bawazir, Hadeel H Alshangiti, Lamiaa A Shaala, Diaa T A Youssef, Faris A Alkhilaiwi","doi":"10.2147/OTT.S467083","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>The increasing incidence of cancer diseases necessitates the urgent exploration of new bioactive compounds. One of the trends in drug discovery is marine sponges which is gaining significant support due to the abundant production of natural pharmaceutical compounds obtained from marine ecosystems. This study evaluates the anticancer properties of an organic extract from the Red Sea sponge <i>Callyspongia siphonella (C. siphonella)</i> on HepG-2 and MCF-7 cancer cell lines.</p><p><strong>Methods: </strong><i>C. siphonella</i> was collected, freeze-dried, and extracted using a methanol-dichloromethane mixture. The extract was analyzed via Liquid Chromatography-Mass Spectrometry. Cytotoxic effects were assessed through cell viability assays, apoptosis detection, cell cycle analysis, mitochondrial membrane potential assays, scratch-wound healing assays, and 3D cell culture assays.</p><p><strong>Results: </strong>Fifteen compounds were identified in the <i>C. siphonella</i> extract. The extract showed moderate cytotoxicity against MCF-7 and HepG-2 cells, with IC<sub>50</sub> values of 35.6 ± 6.9 μg/mL and 64.4 ± 8 μg/mL, respectively, after 48 hours of treatment. It induced cell cycle arrest at the G2/M phase in MCF-7 cells and the S phase in HepG-2 cells. Apoptosis increased significantly in both cell lines, accompanied by reduced mitochondrial membrane potential. The extract inhibited cell migration, with notable reductions after 24 and 48 hours. In 3D cell cultures, the extract had IC<sub>50</sub> values of 5.1 ± 2 μg/mL for MCF-7 and 166.4 ± 27 μg/mL for HepG-2 after 7 days of treatment, showing greater potency in MCF-7 spheres compared to HepG-2 spheres.</p><p><strong>Discussion and conclusion: </strong>The anticancer activity is attributed to the bioactive compounds. The <i>C. siphonella</i> extract's ability to induce apoptosis, disrupt mitochondrial membrane potential, and arrest the cell cycle highlights its potential as a novel anticancer agent. Additional research is required to investigate the underlying mechanism by which this extract functions as a highly effective anticancer agent.</p>","PeriodicalId":19534,"journal":{"name":"OncoTargets and therapy","volume":"17 ","pages":"521-536"},"PeriodicalIF":2.7000,"publicationDate":"2024-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11214578/pdf/","citationCount":"0","resultStr":"{\"title\":\"Red Sea Sponge <i>Callyspongia siphonella</i> Extract Induced Growth Inhibition and Apoptosis in Breast MCF-7 and Hepatic HepG-2 Cancer Cell Lines in 2D and 3D Cell Cultures.\",\"authors\":\"Sana A Fadil, Fadwa A Aljoud, Ahmed R Yonbawi, Ahmad J Almalki, Rawan H Hareeri, Abrar Ashi, Mehal Atallah AlQriqri, Nada S Bawazir, Hadeel H Alshangiti, Lamiaa A Shaala, Diaa T A Youssef, Faris A Alkhilaiwi\",\"doi\":\"10.2147/OTT.S467083\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>The increasing incidence of cancer diseases necessitates the urgent exploration of new bioactive compounds. One of the trends in drug discovery is marine sponges which is gaining significant support due to the abundant production of natural pharmaceutical compounds obtained from marine ecosystems. This study evaluates the anticancer properties of an organic extract from the Red Sea sponge <i>Callyspongia siphonella (C. siphonella)</i> on HepG-2 and MCF-7 cancer cell lines.</p><p><strong>Methods: </strong><i>C. siphonella</i> was collected, freeze-dried, and extracted using a methanol-dichloromethane mixture. The extract was analyzed via Liquid Chromatography-Mass Spectrometry. Cytotoxic effects were assessed through cell viability assays, apoptosis detection, cell cycle analysis, mitochondrial membrane potential assays, scratch-wound healing assays, and 3D cell culture assays.</p><p><strong>Results: </strong>Fifteen compounds were identified in the <i>C. siphonella</i> extract. The extract showed moderate cytotoxicity against MCF-7 and HepG-2 cells, with IC<sub>50</sub> values of 35.6 ± 6.9 μg/mL and 64.4 ± 8 μg/mL, respectively, after 48 hours of treatment. It induced cell cycle arrest at the G2/M phase in MCF-7 cells and the S phase in HepG-2 cells. Apoptosis increased significantly in both cell lines, accompanied by reduced mitochondrial membrane potential. The extract inhibited cell migration, with notable reductions after 24 and 48 hours. In 3D cell cultures, the extract had IC<sub>50</sub> values of 5.1 ± 2 μg/mL for MCF-7 and 166.4 ± 27 μg/mL for HepG-2 after 7 days of treatment, showing greater potency in MCF-7 spheres compared to HepG-2 spheres.</p><p><strong>Discussion and conclusion: </strong>The anticancer activity is attributed to the bioactive compounds. The <i>C. siphonella</i> extract's ability to induce apoptosis, disrupt mitochondrial membrane potential, and arrest the cell cycle highlights its potential as a novel anticancer agent. Additional research is required to investigate the underlying mechanism by which this extract functions as a highly effective anticancer agent.</p>\",\"PeriodicalId\":19534,\"journal\":{\"name\":\"OncoTargets and therapy\",\"volume\":\"17 \",\"pages\":\"521-536\"},\"PeriodicalIF\":2.7000,\"publicationDate\":\"2024-06-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11214578/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"OncoTargets and therapy\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.2147/OTT.S467083\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q3\",\"JCRName\":\"BIOTECHNOLOGY & APPLIED MICROBIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"OncoTargets and therapy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/OTT.S467083","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

简介随着癌症发病率的上升,人们迫切需要探索新的生物活性化合物。海洋海绵是药物发现的趋势之一,由于从海洋生态系统中获取的天然药物化合物产量丰富,海洋海绵正获得越来越多的支持。本研究评估了红海海绵 Callyspongia siphonella(C. siphonella)的有机提取物对 HepG-2 和 MCF-7 癌细胞系的抗癌特性:方法:采集 C. siphonella,冷冻干燥,然后用甲醇-二氯甲烷混合物提取。提取物通过液相色谱-质谱法进行分析。通过细胞活力测定、细胞凋亡检测、细胞周期分析、线粒体膜电位测定、划痕-伤口愈合测定和三维细胞培养测定来评估细胞毒性作用:结果:在虹吸虫提取物中发现了 15 种化合物。提取物对 MCF-7 和 HepG-2 细胞具有中等程度的细胞毒性,处理 48 小时后的 IC50 值分别为 35.6 ± 6.9 μg/mL 和 64.4 ± 8 μg/mL。它诱导 MCF-7 细胞的细胞周期停滞在 G2/M 期,HepG-2 细胞的细胞周期停滞在 S 期。两种细胞系的细胞凋亡都明显增加,同时线粒体膜电位降低。提取物抑制细胞迁移,24 小时和 48 小时后迁移率明显下降。在三维细胞培养中,经 7 天处理后,MCF-7 和 HepG-2 提取物的 IC50 值分别为 5.1 ± 2 μg/mL 和 166.4 ± 27 μg/mL,与 HepG-2 球形细胞相比,MCF-7 球形细胞的 IC50 值更高:抗癌活性归功于生物活性化合物。C.siphonella萃取物能够诱导细胞凋亡、破坏线粒体膜电位和阻滞细胞周期,这凸显了其作为新型抗癌剂的潜力。还需要进行更多的研究,以探究这种提取物发挥高效抗癌作用的内在机制。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Red Sea Sponge Callyspongia siphonella Extract Induced Growth Inhibition and Apoptosis in Breast MCF-7 and Hepatic HepG-2 Cancer Cell Lines in 2D and 3D Cell Cultures.

Introduction: The increasing incidence of cancer diseases necessitates the urgent exploration of new bioactive compounds. One of the trends in drug discovery is marine sponges which is gaining significant support due to the abundant production of natural pharmaceutical compounds obtained from marine ecosystems. This study evaluates the anticancer properties of an organic extract from the Red Sea sponge Callyspongia siphonella (C. siphonella) on HepG-2 and MCF-7 cancer cell lines.

Methods: C. siphonella was collected, freeze-dried, and extracted using a methanol-dichloromethane mixture. The extract was analyzed via Liquid Chromatography-Mass Spectrometry. Cytotoxic effects were assessed through cell viability assays, apoptosis detection, cell cycle analysis, mitochondrial membrane potential assays, scratch-wound healing assays, and 3D cell culture assays.

Results: Fifteen compounds were identified in the C. siphonella extract. The extract showed moderate cytotoxicity against MCF-7 and HepG-2 cells, with IC50 values of 35.6 ± 6.9 μg/mL and 64.4 ± 8 μg/mL, respectively, after 48 hours of treatment. It induced cell cycle arrest at the G2/M phase in MCF-7 cells and the S phase in HepG-2 cells. Apoptosis increased significantly in both cell lines, accompanied by reduced mitochondrial membrane potential. The extract inhibited cell migration, with notable reductions after 24 and 48 hours. In 3D cell cultures, the extract had IC50 values of 5.1 ± 2 μg/mL for MCF-7 and 166.4 ± 27 μg/mL for HepG-2 after 7 days of treatment, showing greater potency in MCF-7 spheres compared to HepG-2 spheres.

Discussion and conclusion: The anticancer activity is attributed to the bioactive compounds. The C. siphonella extract's ability to induce apoptosis, disrupt mitochondrial membrane potential, and arrest the cell cycle highlights its potential as a novel anticancer agent. Additional research is required to investigate the underlying mechanism by which this extract functions as a highly effective anticancer agent.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
OncoTargets and therapy
OncoTargets and therapy BIOTECHNOLOGY & APPLIED MICROBIOLOGY-ONCOLOGY
CiteScore
9.70
自引率
0.00%
发文量
221
审稿时长
1 months
期刊介绍: OncoTargets and Therapy is an international, peer-reviewed journal focusing on molecular aspects of cancer research, that is, the molecular diagnosis of and targeted molecular or precision therapy for all types of cancer. The journal is characterized by the rapid reporting of high-quality original research, basic science, reviews and evaluations, expert opinion and commentary that shed novel insight on a cancer or cancer subtype. Specific topics covered by the journal include: -Novel therapeutic targets and innovative agents -Novel therapeutic regimens for improved benefit and/or decreased side effects -Early stage clinical trials Further considerations when submitting to OncoTargets and Therapy: -Studies containing in vivo animal model data will be considered favorably. -Tissue microarray analyses will not be considered except in cases where they are supported by comprehensive biological studies involving multiple cell lines. -Biomarker association studies will be considered only when validated by comprehensive in vitro data and analysis of human tissue samples. -Studies utilizing publicly available data (e.g. GWAS/TCGA/GEO etc.) should add to the body of knowledge about a specific disease or relevant phenotype and must be validated using the authors’ own data through replication in an independent sample set and functional follow-up. -Bioinformatics studies must be validated using the authors’ own data through replication in an independent sample set and functional follow-up. -Single nucleotide polymorphism (SNP) studies will not be considered.
期刊最新文献
Advances in the Treatment of Rare Mutations in Non-Small Cell Lung Cancer. Analysis of Lymphovascular Infiltration and Tumor-Associated Macrophages in Cervical Cancer Immunoescape. Concentrations of Irinotecan and SN-38 in the Ascites and the Fluid Product of Cell-Free and Concentrated Ascites Reinfusion Therapy 9 Days After Administration of Irinotecan in a Patient with Gastric Cancer: A Case Report. Identification of Cuproptosis-Related Genes for Molecular Subtyping: Predicting Prognostic and Therapeutic Response in Glioma. Four Cases with FUS/CHOP Fusion Gene Products Positive Myxoid Liposarcoma Responding Effectively to Trabectedin Monotherapy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1